Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Magnusson, Kristina, de Wit, Meike, Brennan, Donal J., Johnson, Louis B., McGee, Sharon F., Lundberg, Emma, Naicker, Kirsha, Klinger, Rut, Kampf, Caroline, Asplund, Anna, Wester, Kenneth, Gry, Marcus, Bjartell, Anders, Gallagher, William M., Rexhepaj, Elton, Kilpinen, Sami, Kallioniemi, Olli-Pekka, Belt, Eric, Goos, Jeroen, Meijer, Gerrit, Birgisson, Helgi, Glimelius, Bengt, Borrebaeck, Carl A.K., Navani, Sanjay, Uhlén, Mathias, O'Connor, Darran P., Jirström, Karin, Pontén, Fredrik·2011·American Journal of Surgical Pathology

Abstract

The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated transcription factor and epigenetic regulator, was identified as a tissue type-specific protein when screening protein expression patterns in human normal and cancer tissues using an antibody-based proteomics approach. In this respect, the SATB2 protein shows a selective pattern of expression and, within cells of epithelial lineages, SATB2 expression is restricted to glandular cells lining the lower gastrointestinal tract. The expression of SATB2 protein is primarily preserved in cancer cells of colorectal origin, indicating that SATB2 could function as a clinically useful diagnostic marker to distinguish colorectal cancer (CRC) from other types of cancer. The aim of this study was to further explore and validate the specific expression pattern of SATB2 as a clinical biomarker and to compare SATB2 with the well-known cytokeratin 20 (CK20). Immunohistochemistry was used to analyze the extent of SATB2 expression in tissue microarrays with tumors from 9 independent cohorts of patients with primary and metastatic CRCs (n=1882). Our results show that SATB2 is a sensitive and highly specific marker for CRC with distinct positivity in 85% of all CRCs, and that SATB2 and/or CK20 was positive in 97% of CRCs. In conclusion, the specific expression of SATB2 in a large majority of CRCs suggests that SATB2 can be used as an important complementary tool for the differential diagnosis of carcinoma of unknown primary origin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/pas.0b013e31821c3dae

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 256

Metadata

Authors
Magnusson, K., de Wit, M., Brennan, D. J., Johnson, L. B., McGee, S. F., Lundberg, E., Naicker, K., Klinger, R., Kampf, C., Asplund, A., Wester, K., Gry, M., Bjartell, A., Gallagher, W. M., Rexhepaj, E., Kilpinen, S., Kallioniemi, O.-P., Belt, E., Goos, J., Meijer, G., Birgisson, H., Glimelius, B., Borrebaeck, C. A. K., Navani, S., Uhlén, M., O'Connor, D. P., Jirström, K., & Pontén, F.
Venue
American Journal of Surgical Pathology
Published
2011-07
Volume
35
Issue
7
Pages
937-948
ISSN
0147-5185 (ISSN-L)
OpenAlex
W2076863148
Cited by
256
References
43
FWCI
4.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas. https://app.cochat.ai/papers/10.1097/pas.0b013e31821c3dae
The paper
Magnusson, K., de Wit, M., Brennan, D. J., Johnson, L. B., McGee, S. F., Lundberg, E., Naicker, K., Klinger, R., Kampf, C., Asplund, A., Wester, K., Gry, M., Bjartell, A., Gallagher, W. M., Rexhepaj, E., Kilpinen, S., Kallioniemi, O.-P., Belt, E., Goos, J., . . . Pontén, F. (2011). SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas. American Journal of Surgical Pathology. https://doi.org/10.1097/pas.0b013e31821c3dae

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.